1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDoW Breast Cancer, Breakthrough Award Level 4 is sponsored by Dept. of the Army -- USAMRAA. This award supports breakthrough research in breast cancer at Level 4.
Specific research areas and requirements would be detailed in the official program announcement.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
eBRAP Online Application Submission Your eBRAP session will expire after 15 minutes of inactivity. Electronic Biomedical Research Application Portal Action Required : Provide/Verify UEI# in eBRAP. org Organization Profile As of April 4th 2022 , eBRAP has transitioned from use of DUNS # to the UEI # issued by Sam.
gov. In order for eBRAP to process any applications submitted through Grants. gov, the UEI must be entered into the Organizational Profile. Where possible a UEI has been pre-populated in eBRAP.
org for your organization as registered in Sam. gov. Please review and update the UEI as necessary in eBRAP. DoD organizations which do not have a UEI must enter a DoDAAC.
Steps to Follow to verify/update Organization Information: Click on "My Organizations" in the dropdown menu located to the left of the Log Out button Click on Organization Profile Tab which will display current details for the organization you Scroll to the bottom of the page and click the "Edit Organization" button Make any necessary changes to the profile including entering the UEI Please contact help@ebrap.
org for assistance or if you wish to deactivate your account if no Breast Cancer Research Program(BCRP) Synopsis of BCRP Award Mechanisms General Application Instructions Breakthrough Award Level 3 FY26 BCRP Breakthrough Award - Funding Level 3 Program Announcement - (Pre-application - Pre-Proposal) Breakthrough Award Level 4 FY26 BCRP Breakthrough Award Level 4 Program Announcement - (Pre-application - Pre-Proposal) Transformative Breast Cancer Consortium Award FY26 BCRP Transformative Breast Cancer Consortium Award Program Announcement - (Pre-application - Pre-Proposal) NOTE: Award mechanism-specific forms shown above supercede the generic documents below.
If the form is not listed with the award mechanism, please use the generic version of the form CDMRP Video Series and FAQ Journey of an Application: CDMRP Two Tier Review Process Frequently Asked Questions Generic Forms for Application Submission Suggested Quad Chart Template (Legacy) Suggested Quad Chart Template (NEW, PPTX version) Suggested Intragovernmental/Intramural Budget (NEW) Common Blinding Mistakes and How to Avoid Them Example: Assembling a Clinical Research and/or Clinical Trial Statement of Work Example: Assembling a Generic Statement of Work Public Health Service Inclusion Enrollment Report Suggested Data Management Plan Format Regulatory Document Forms Safety & Environmental Resources Environmental Compliance Assurance eBRAP Regulatory File Drop-Off Instruction Guide Animal Care and Use Review Office Office of Human Research Oversight Resources and Overview Award Expiration Transition Plan Annual/Final Technical Progress Report Template Semi-Annual Technical Progress Report Template Quarterly Technical Progress Report Template Public Health Service Inclusion Enrollment Report Technical Reporting Requirements DD882- Report of Inventions and Subcontract (New) SF425 - Federal Financial Report Resources and Reference Material General Application Instructions (FY25) General Application Instructions (FY26) --NEW !!
-- eBRAP Regulatory File Drop-Off Instruction Guide eBRAP Technical Report Submission Guide Guide for Funded Investigators (NEW as of 2/3/25) Guide for Intragovernmental & Intramural Applicants Research Classification Codes and Guidance Directive on Avoiding Research Duplication Planning and Executing a Successful Research Consortium or Complex Collaboration Directive on Sharing Data and Research Resources VA/DoD Collaboration Guidebook for Healthcare Research 2013 Directive on Inclusion of Women and Minorities as Subjects in Clinical Research Frequently Asked Questions for Directive on Inclusion of Women and Minorities Directive on Sex as a Biological Variable in Research Frequently Asked Questions for Directive on Sex as a Biological Variable Public Health Service Inclusion Enrollment Report You may get a free copy of the Adobe® Reader® to view the PDF files on this page.
To save a copy of the forms above, right-click on the name and select from the pop-up menu that is displayed either "Save Target As..." , or "Save Link As..." or something similar in your browser.
AFFILIATED ORGANIZATIONS: EXTERNAL LINK DISCLAIMER: This website has links to other websites. The appearance of external hyperlinks does not constitute endorsement by the U.S. Army of this Web site or the information, products, or services contained therein. Such links are provided consistent with the stated purpose of this Web site.
Once you link to Controlled Unclassified Information Monday to Friday (except Holidays) 8:00 a. m. - 5:00 p.
m. eastern time (ET) U.S. Army Medical Research and Development Command ATTN: FCMR-CD (Program Name) 1077 Patchel Street (Building 1077) Fort Detrick, MD 21702-5024 Authorities : Section 113, Title 10, United States Code: Secretary of Defense Federal Acquisition Purposes : The information will be used in connection with the selection of qualified proposals submitted by applicants in order to make research awards.
To permit authorized individuals to view their data for purpose of verifying its accuracy and to update the data when it is not current or is inaccurate.
To audit user access to ensure that access is only granted to users that are authorized access to the information Routine Uses : The information requested may be disclosed to qualified reviewers and staff assistants as part of the proposal review process, funding decisions, or the administration of research awards; or to other government agencies for comparison of funded research.
eBRAP does not share information with any private organizations and does not collect information for commercial marketing. Disclosure : Submission of the information is voluntary. Failure to provide full and complete information, however, may reduce the possibility of receiving a research award.
According to the current listing, eligibility includes: Organizations. Confirm the full requirements in the official notice before applying.
DoW Breast Cancer, Breakthrough Award Level 4 is funded by Dept. of the Army -- USAMRAA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.Distinctive Features: The FY26 CTRA offers two funding levels:• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.• Funding Level 2 to support larger, more complex preclinical and/or clinical research.The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed. Funding Opportunity Number: HT942526DMDRPCTRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $8.5M total program funding.
DoW Duchenne Muscular Dystrophy, Idea Development Award is sponsored by Dept. of the Army -- USAMRAA. Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation.
After SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read articleDARPA transferred its first autonomous-ready H-60Mx Black Hawk to the Army on March 20, capping a decade of ALIAS research. Now the same technology underpins an SBIR XL opportunity for small businesses building wildfire autonomy.
Read article